Call +07947 727375

About Nine-TZ

Overview

Since we opened the business in 2006 people have asked about our name. Well, Nine-TZ represents the nine time zones that we cover, between Europe and the West Coast of the USA.

Not everything we do is Transatlantic: we have worked with companies in other regions including Australia, Japan, India and Russia. We believe what we deliver is important, not just where.

Before starting Nine-TZ we worked together twice previously; first in Big Pharma, the second time in transatlantic investment and drug development. Along the way, we have worked with many smart, talented and experienced professionals who remain part of our network.

Nine-TZ brings you that collective experience, in Europe, America, or anywhere else where you need some help.

 

Dr Kevin Bilyard - Nine-TZ Managing Partner

Dr Kevin Bilyard

Managing Partner (UK)

Kevin has extensive experience of new product development and growing businesses. He started with Smith Kline & French (now GSK) and then ICI Pharmaceuticals (now AZ) working in research, product development and strategic marketing.

In 1997 he joined Quadrant Healthcare as Product Development Director and was part of the management team that led the company’s IPO on the London Stock Exchange in 1998.

He gained experience in M&A transactions and formation of joint ventures and, when Quadrant was acquired by Elan in 2000, he established Development and Management Resources, an independent business providing advisory services which later became Nine-TZ Healthcare Ventures.

He has held executive and advisory roles, including board level positions, with several emerging biotech companies and became CEO of Immodulon Therapeutics, an immuno-oncology company, soon after its formation in 2007.

He graduated with first class honors in Medicinal Chemistry from University College London where he also completed research leading to his PhD.

Christopher O'Toole - Nine-TZ Managing Partner

Christopher O'Toole

Managing Partner (USA)

Chris is a healthcare professional with 30 years’ commercial experience in marketing and business development positions in the pharmaceutical industry and service sector.

While in the UK, Chris held sales and international product management positions at Smith Kline & French and Fisons Pharmaceuticals. In 1989 he relocated to the United States to join the global marketing group at Schering-Plough.

For the past 20 years, he has held senior leadership positions with medical-marketing consultancies, including a publicly-listed international medical communications company. He also led US, European and Japanese marketing development for the healthcare division of a multinational publishing and education company.

In 2006, Chris co-founded Nine-TZ Healthcare Ventures, a business and product development consultancy, providing technical, product, and business development services, as well as interim management, for biotechnology and pharmaceutical companies.

He is a member of the Executive Advisory Board of the Galien Foundation, an organization that fosters, recognizes, and rewards excellence in scientific innovation to improve the state of human health.